The Global Huntington's Disease Treatment Market Growth Accelerated By Increasing Disease Prevalence
Huntington's Disease Treatment Market
Huntington's disease is a severe genetic disorder that causes the degeneration of nerve cells in the brain, leading to uncontrolled movements, loss of intellectual abilities, and psychological symptoms.
The
global Huntington's Disease Treatment
Market is estimated to be valued at Us$
0.55 Mn in 2024 and is expected to exhibit a CAGR Of 4.3% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent
Market Insights.
Treatment options for Huntington's disease aim to manage its motor, cognitive,
and psychiatric symptoms in order to improve the quality of life. Currently
available medicines help reduce involuntary movements and ease mood symptoms
caused by the disease. However, there is no cure for Huntington’s as the drugs
only mask symptoms and do not slow down or stop the progression of the disease.
The need for safe and effective treatment options is expected to drive the
growth of the market over the coming years.
Market key trends:
The increasing prevalence of Huntington's disease is expected to drive the
growth of the treatment market. According to the Huntington's Disease Society
of America, around 30,000 people in the United States have HD, with an
additional 200,000 at-risk of inheriting the faulty gene. The rising prevalence
can be attributed to advancements in genetic testing that allow for the
identification of individuals with huntingtin gene mutations. Growing disease
awareness and expanded access to genetic testing are facilitating early
diagnosis, which in turn is boosting the demand for HD therapeutics. Moreover,
a strong product pipeline consisting of drugs targeting the underlying cause is
anticipated to present lucrative opportunities in the market over the forecast
period.
Segment Analysis
The global Huntington's Disease Treatment market is segmented into type,
treatment, and end-user. By type, the genetic testing segment dominates the
market due to the growing use of genetic testing for the diagnosis of
Huntington's disease. Genetic testing helps in determining whether a person has
the abnormal Huntington's gene and this accurate diagnosis aids in better
treatment planning.
Key Takeaways
The Global Huntington's Disease Treatment Market Demand
is expected to witness high growth during the forecast period from 2024 to
2031. The global Huntington's Disease Treatment Market is estimated to be
valued at US$ 0.55 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over
the forecast period 2024 to 2031.
Regional analysis :
North
America region is expected to maintain its dominance in the global Huntington's
disease treatment market during the forecast period owing to rising prevalence
of Huntington's disease and growing investment in research activities for
developing advanced treatment. According to the Huntington's Disease Society of
America, around 30,000 people in the United States have Huntington's disease.
Additionally, availability of funding programs from private and government
organizations and presence of leading players focused on conducting clinical
trials for Huntington's disease treatment are boosting the market growth in
this region.
Key players :
Key
players operating in the Huntington's Disease Treatment market are Unilever
Plc., Coty Inc., Johnson & Johnson Inc., Proctor & Gamble Co.,
L€TMOreal S.A., Revlon Inc., Kao Corporation, Avon Products Inc., Beiersdorf
AG., Colgate Palmolive Company, Natura & co., and Estee Lauder Inc.
Get more insights on this topic :
Comments
Post a Comment